HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

1-Chlorodibenzo-P-dioxin

HCID 37207
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
35656-51-0
Standard SMILES
Clc1cccc2c1Oc1ccccc1O2
InChIKey
VGGGRWRBGXENKI-UHFFFAOYSA-N
Molecular formula
C12H7ClO2
Average molar mass
218.63 g/mol
Monoisotopic mass
218.0134572

Overview

1-Chlorodibenzo-p-dioxin is one of 75 chlorinated dibenzo-p-dioxin (CDD) congeners. CDDs are a class of manufactured chemicals that consist of dioxin skeletel structures with chlorine substituents. They are also persistent organic pollutants (POPs), thus their production is regulated in most areas. Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

Names & identifiers

Preferred name
1-Chlorodibenzo-P-dioxin
IUPAC
1-chlorodibenzo-p-dioxin
English name
1-CHLORODIBENZO-P-DIOXIN
Molecular formula
C12H7ClO2
Molecular weight
218.64

Names & synonyms

1-Chlorodibenzo-p-dioxin39227-53-71-Chlorodibenzodioxin1-ChlorooxanthreneDibenzo-p-dioxin, 1-chloro-BRN 1571801UNII-BT477ZL85JDibenzo(b,e)(1,4)dioxin, 1-chloro-Dibenzo[b,e][1,4]dioxin, 1-chloro-BT477ZL85JChlorodibenzo(b,e)(1,4)dioxinPCDD 1
Show more names
1-CDD1-chloro-dibenzo-p-dioxiCHLORODIBENZO-PARA-DIOXIN1-Chlorodibenzo[1,4]dioxin1-CHLORODIBENZO-PARA-DIOXIN1-MONOCHLORODIBENZO-PARA-DIOXIN
5-19-02-00039 (Beilstein Handbook Reference)RefChem:754441-CHLORODIBENZP-P-DIOXINVGGGRWRBGXENKI-UHFFFAOYSA-N35656-51-0CHEMBL137620UNII-ZW6B72Q1U6Dibenzo(b,e)(1,4)dioxin, chloro-

Database identifiers

CAS
35656-51-0、39227-53-7
PubChem CID
37207
DTXSID
DTXSID80872020
ChEMBL
CHEMBL137620

Properties

Computed structural properties

XLogP
5
Topological polar surface area
18.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
0
Heavy atoms
15
Formal charge
0
Complexity
234

Experimental & physicochemical properties

SpringerMaterials PropertiesBoiling point
LogP4.75

Physicochemical properties

Melting point
104.85 °C · 104.85°C
Boiling point
283.66 °C · 283.66°C (rough estimate)
Density
1.366 · 1.3660 (estimate)
refractive index
1.634 · 1.6340 (estimate)
Water Solubility
417 ug/L · 417ug/L(25 ºC)
Henry's Law Constant
1.6 · 1.6×10-1 mol/(m3Pa) at 25℃, Duchowicz et al. (2020)
EWG's Food Scores
1 · 1
FDA UNII
477 ZL85J · BT477ZL85J
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety & protection

Minimum Risk LevelAcute Oral: 0.0002 ug/kg/day (L134) Intermediate Oral: 0.00002 ug/kg/day (L134) Chronic Oral: 0.000001 ug/kg/day (L134)

Toxicology

TreatmentTreatment of CDD exposure may include washing the area of contact, GI decontamination, administering an IV, or forced alkaline diuresis. (L346)
Health Effects · 1 item

Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. (L177, L178)

Exposure RoutesOral (L177) ; inhalation(L177) ; dermal (L177)
Toxicity Summary · 1 item

CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. (L177)

Signs and Symptoms

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the faeces, though smaller amounts are excreted in the urine and via lactation. (L177)

Uses & manufacturing

Uses · 1 item

Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

Applications

Uses1-Chlorodibenzo-p-dioxin is used as a standard for environmental testing and research such as in the study of tetrachlorodibenzo-p-dioxin impairment on human B lympopoiesis.

Upstream & downstream products

Downstream products

DIBENZO-P-DIOXIN

Suppliers4 total

天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
BT477ZL85J
Nikkaji
J74.763G
Precautionary statements
280 · P280-P305+P351+P338
RIDADR
3077 · 3077
HazardClass
9 · 9
PackingGroup
I
In addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)

Safety data

ridadr
3077
Signal word
Warning
Symbol(GHS)
GHS07
hazard_class
9
packing_group
I
Hazard statements
H302-H315-H319-H335
Precautionary statements
P280-P305+P351+P338
珠海奥博凯生物医药技术有限公司400-0628126 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]